BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →

Loading IPHA charts…

Search ticker or company⌘K

IPHA

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

IPHA · Innate Pharma SA fundamentals · vpside

⌘K

IPHAMarket cap $133M/Last filing 20-F, FY25 · 1 Apr 2026/IPHAMarket cap $133M/Last filing 20-F, FY25 · 1 Apr 2026/IPHAMarket cap $133M/Last filing 20-F, FY25 · 1 Apr 2026/IPHAMarket cap $133M/Last filing 20-F, FY25 · 1 Apr 2026/

Filings synced 13:22 · Prices: prior close 27 Oct

IPHA

Innate Pharma SA

Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

—

Not reported in this company’s filings

Company filingsvpside.com

Gross margin, trailing twelve months

—

Not reported in this company’s filings

Company filingsvpside.com

Cash and cash equivalents, quarter-end

—

Not reported in this company’s filings

Company filingsvpside.com

Free cash flow, trailing twelve months

—

Not reported in this company’s filings

Company filingsvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters